Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo

Tara Samra1, Tatiana Gomez-Gomez1, Kinga Linowiecka1,2

  • 1Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33125, USA.

Insights

Melatonin demonstrates anti-aging effects on aged human skin ex vivo. It downregulates aging pathways and boosts collagen and mitochondrial markers, suggesting potential for skin rejuvenation therapies.

Area of Science:

  • Dermatology
  • Gerontology
  • Molecular Biology

Background:

  • Human skin aging involves physiological decline, necessitating senotherapeutics.
  • Melatonin shows in vitro and in vivo anti-aging potential, but its ex vivo effects on aged human skin are unproven.
  • Understanding melatonin's impact on aged skin biomarkers is crucial for developing effective anti-aging strategies.

Purpose of the Study:

  • To investigate the anti-aging effects of melatonin on organ-cultured aged human eyelid skin ex vivo.
  • To assess melatonin's impact on key aging biomarkers in both the epidermis and dermis.
  • To determine if melatonin can reverse or mitigate signs of aging in human skin.

Main Methods:

  • Organ-cultured, full-thickness human eyelid skin from aged donors (49-77 years) was treated with melatonin (100-200 µM) or vehicle for 6 days.
  • Quantitative immunohistochemistry was employed to assess core aging biomarkers, including pathway activity, protein expression, and structural organization.
  • Specific markers analyzed included mTORC1 activity (S6 phosphorylation), MMP-1, collagen 17A1, mitochondrial proteins (TFAM, MTCO-1, VDAC), VEGF-A, fibrillin-1, SIRT-1, lamin-B1, p16INK4, and collagen I.

Main Results:

  • Melatonin (200 µM) significantly downregulated epidermal mTORC1 pathway activity and MMP-1 expression.
  • Transmembrane collagen 17A1 and mitochondrial markers (TFAM, MTCO-1, VDAC) were significantly upregulated by melatonin.
  • Melatonin (100 µM) increased epidermal VEGF-A expression, and in the dermis, it enhanced fibrillin-1 expression and organization, improving the extracellular matrix.

Conclusions:

  • This ex vivo study provides proof of principle for melatonin's anti-aging effects in aged human skin.
  • Melatonin exerts differential effects on aged epidermis and dermis, downregulating some aging markers while upregulating others beneficial for skin health.
  • The findings suggest melatonin's potential as a senotherapeutic agent for human skin rejuvenation.